Ascendis Pharma
A Global Medical Scientist in the Endocrine and Rare Disease Medical Sciences department drives scientific strategy and operational excellence for complex therapeutic areas. The role involves leading global clinical development programs, managing cross-functional teams, and ensuring regulatory compliance across international markets.
Headquarters
Hellerup, Hovedstaden, Denmark
Company Size
501-1000 employees
Founded
2007
Ascendis Pharma is a biopharmaceutical company dedicated to developing innovative therapies for patients with rare endocrine diseases and cancer. Utilizing its proprietary TransCon technology platform, the company aims to create a fully integrated biopharma entity that improves patient care and outcomes. With a focus on science and patient needs, Ascendis Pharma is committed to making a meaningful difference for patients, caregivers, and healthcare professionals worldwide.
Ascendis Pharma A/S $ASND Shares Bought by Atika Capital Management LLC
8 hours ago
Ascendis Pharma grants 22,480 employee warrants at $240.52 per share
17 hours ago
Assessing Ascendis Pharma (NasdaqGS:ASND) Valuation After FDA Accelerated Approval Of YUVIWEL
2 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ascendis Pharma.
Ascendis Pharma didn’t post a salary, so this is our estimate from similar listings.
10% below the average for this role
Pfizer Posts Cancer Data, Ascendis Wins FDA Approval and More
2 days ago
Global Medical Director Gastroenterology&Raredisease
Alfasigma
Medical Manager, Rare Disease, Gulf
AstraZeneca
Medical Director, Global Medical Affairs, Rare Disease
Amgen
Global Medical Affairs Asset Lead (GMAL) Rare Disease
Amgen
Executive Director, Head of US Rare Endocrinology and Rare Tumors
AstraZeneca
Global Medical Affairs Asset Lead (GMAL) Rare Disease
lifelancer